Loading…
Sectoral / Thematic · SBI Mutual Fund · AMFI code 100644SBI Healthcare Opportunities Fund
Disclosed for 41 months, Jan 2023 to Sep 2026.
Portfolio value
₹3,989 Cr
down ₹141 Cr vs Nov 2025
- Stocks held
- 32
- up 1 vs Nov 2025
- Top 10 weight
- 50.5%
- of the portfolio in its ten largest
- Cash & debt
- 3.4%
- cash, money market and debt
- Moves this month
- 2 in · 1 out
- added to 6, trimmed 22
SBI Healthcare Opportunities Fund is an active equity fund in the Sectoral / Thematic category from SBI Mutual Fund. In December 2025 it disclosed 32 stocks worth ₹3,989 Cr, down ₹141 Cr from Nov 2025. Its largest positions were Sun Pharmaceutical Industries Limited (11.6%), Divi's Laboratories Limited (7.1%), Max Healthcare Institute Limited (5.2%); the ten largest together made up 50.5% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 70.6% of its equity. Cash and debt stood at 3.4%. Compared with Nov 2025 the fund entered 2 new stocks and exited 1.
Against 226 other Sectoral / Thematic funds
Concentration
61%
Top-10 weight is higher than 61% of peers
Breadth
18%
Holds more stocks than 18% of peers
Cash
52%
Holds more cash than 52% of peers
Holdings in December 2025
Download CSVEvery line the fund disclosed, with the change against Nov 2025. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 11.64%
- Δ weight
- down 0.33 pts
- Value
- ₹464 Cr
- Δ value
- down ₹30.2 Cr
- Status
- Trimmed
- Weight
- 7.05%
- Δ weight
- up 0.15 pts
- Value
- ₹281 Cr
- Δ value
- down ₹3.7 Cr
- Status
- Trimmed
- Weight
- 5.24%
- Δ weight
- down 0.39 pts
- Value
- ₹209 Cr
- Δ value
- down ₹23.5 Cr
- Status
- Trimmed
- Weight
- 4.44%
- Δ weight
- up 0.21 pts
- Value
- ₹177 Cr
- Δ value
- up ₹2.3 Cr
- Status
- Added
- Weight
- 3.89%
- Δ weight
- up 0.39 pts
- Value
- ₹155 Cr
- Δ value
- up ₹10.7 Cr
- Status
- Added
- Weight
- 3.86%
- Δ weight
- up 0.26 pts
- Value
- ₹154 Cr
- Δ value
- up ₹5.2 Cr
- Status
- Added
- Weight
- 3.85%
- Δ weight
- down 0.16 pts
- Value
- ₹153 Cr
- Δ value
- down ₹11.9 Cr
- Status
- Trimmed
- Weight
- 3.79%
- Δ weight
- down 0.66 pts
- Value
- ₹151 Cr
- Δ value
- down ₹32.6 Cr
- Status
- Trimmed
- Weight
- 3.63%
- Δ weight
- down 0.37 pts
- Value
- ₹145 Cr
- Δ value
- down ₹20.5 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 3.33%
- Δ weight
- down 0.78 pts
- Value
- ₹133 Cr
- Δ value
- down ₹37.1 Cr
- Status
- Trimmed
- Weight
- 3.16%
- Δ weight
- up 0.07 pts
- Value
- ₹126 Cr
- Δ value
- down ₹1.4 Cr
- Status
- Trimmed
- Weight
- 3.14%
- Δ weight
- down 0.06 pts
- Value
- ₹125 Cr
- Δ value
- down ₹7 Cr
- Status
- Trimmed
- Weight
- 3.10%
- Δ weight
- down 0.24 pts
- Value
- ₹124 Cr
- Δ value
- down ₹14.1 Cr
- Status
- Trimmed
- Weight
- 3.09%
- Δ weight
- down 0.16 pts
- Value
- ₹123 Cr
- Δ value
- down ₹10.9 Cr
- Status
- Trimmed
- Weight
- 3.02%
- Δ weight
- up 0.05 pts
- Value
- ₹120 Cr
- Δ value
- down ₹2.4 Cr
- Status
- Trimmed
- Weight
- 2.97%
- Δ weight
- up 0.03 pts
- Value
- ₹119 Cr
- Δ value
- down ₹2.9 Cr
- Status
- Trimmed
- Weight
- 2.91%
- Δ weight
- down <0.01 pts
- Value
- ₹116 Cr
- Δ value
- down ₹4.2 Cr
- Status
- Trimmed
- Weight
- 2.76%
- Δ weight
- up 0.01 pts
- Value
- ₹110 Cr
- Δ value
- down ₹3.6 Cr
- Status
- Trimmed
- Weight
- 2.67%
- Δ weight
- down 0.23 pts
- Value
- ₹107 Cr
- Δ value
- down ₹13.4 Cr
- Status
- Trimmed
- Weight
- 2.67%
- Δ weight
- down 0.15 pts
- Value
- ₹106 Cr
- Δ value
- down ₹9.9 Cr
- Status
- Trimmed
- Weight
- 2.59%
- Δ weight
- down 0.39 pts
- Value
- ₹103 Cr
- Δ value
- down ₹19.9 Cr
- Status
- Trimmed
- Weight
- 2.43%
- Δ weight
- down 0.04 pts
- Value
- ₹96.9 Cr
- Δ value
- down ₹5.2 Cr
- Status
- Trimmed
- Weight
- 2.12%
- Δ weight
- up 0.13 pts
- Value
- ₹84.7 Cr
- Δ value
- up ₹2.2 Cr
- Status
- Added
- Weight
- 2.08%
- Δ weight
- down <0.01 pts
- Value
- ₹82.8 Cr
- Δ value
- down ₹3.1 Cr
- Status
- Trimmed
- Weight
- 1.92%
- Δ weight
- up 1.20 pts
- Value
- ₹76.8 Cr
- Δ value
- up ₹47 Cr
- Status
- Added
- Weight
- 1.60%
- Δ weight
- up 0.15 pts
- Value
- ₹63.7 Cr
- Δ value
- up ₹3.8 Cr
- Status
- Added
- Weight
- 1.59%
- Δ weight
- down 0.05 pts
- Value
- ₹63.4 Cr
- Δ value
- down ₹4.3 Cr
- Status
- Trimmed
- Weight
- 1.25%
- Δ weight
- up 0.05 pts
- Value
- ₹49.9 Cr
- Δ value
- up ₹13 L
- Status
- Held
- Weight
- 1.01%
- Δ weight
- up 0.03 pts
- Value
- ₹40.4 Cr
- Δ value
- down ₹7 L
- Status
- Held
- Weight
- 0.92%
- Δ weight
- up 0.92 pts
- Value
- ₹36.8 Cr
- Δ value
- up ₹36.8 Cr
- Status
- New
- Weight
- 0.85%
- Δ weight
- up <0.01 pts
- Value
- ₹33.9 Cr
- Δ value
- down ₹1 Cr
- Status
- Trimmed
- Weight
- 0.84%
- Δ weight
- down 0.02 pts
- Value
- ₹33.6 Cr
- Δ value
- down ₹2 Cr
- Status
- Trimmed
- Weight
- 0.51%
- Δ weight
- up 0.51 pts
- Value
- ₹20.4 Cr
- Δ value
- up ₹20.4 Cr
- Status
- New
- 364 DAY T-BILLDebt
- Weight
- 0.07%
- Δ weight
- up <0.01 pts
- Value
- ₹2.9 Cr
- Δ value
- up ₹1 L
- Status
- Held
What changed, Nov 2025 to Dec 2025
New New positions (2)
- Nephrocare Health Services Ltd0.9% · ₹36.8 Cr
- Corona Remedies Limited0.5% · ₹20.4 Cr
Exited Exited (1)
- Rainbow Childrens Medicare Limitedwas 0.1% · ₹4.9 Cr
Added Biggest additions
- Sudeep Pharma Limitedup ₹47 Cr (+1.20% pts)
- Laurus Labs Limitedup ₹10.7 Cr (+0.39% pts)
- Torrent Pharmaceuticals Limited ₹5.2 Cr (+0.26% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Nov 2025, the weight rose most in Chemicals & Petrochemicals (+1.3 pts), and fell most in Pharmaceuticals & Biotechnology (−0.8 pts) and Healthcare Services (−0.3 pts).
- Chemicals & Petrochemicals3.9% → 5.1%+1.3 pts
- Pharmaceuticals & Biotechnology71.4% → 70.6%−0.8 pts
- Healthcare Services20.8% → 20.5%−0.3 pts
- Healthcare Equipment & Supplies2.9% → 2.8%−0.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Dec 2024 | Jun 2025 | Sep 2025 | Nov 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 67.7% | 69.5% | 70.7% | 71.4% | 70.6% |
| Healthcare Services | 25.0% | 24.7% | 22.5% | 20.8% | 20.5% |
| Chemicals & Petrochemicals | 3.5% | 2.9% | 2.8% | 3.9% | 5.1% |
| Healthcare Equipment & Supplies | 3.7% | 3.0% | 3.1% | 2.9% | 2.8% |
| Retailing | — | — | 0.9% | 1.0% | 1.0% |
Allocation in Dec 2025change vs Nov 2025
- Pharmaceuticals & Biotechnology (21)70.6%▼ 0.8 pts
- Healthcare Services (7)20.5%▼ 0.3 pts
- Chemicals & Petrochemicals (2)5.1%▲ 1.3 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Dec 2025
3.4%
▼ 0.8 pts vs Nov 2025
- Cash alone
- 3.3%
- cash and net receivables
- A year earlier
- 3.4%
- Dec 2024
- Last 12 months
- 1.8% – 4.2%
- lowest to highest · record 7.8% in May 2023
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.